Biological aspects of erythromycin and its semi-synthetic derivatives

Journal of Scientific and Industrial Research

Volumn 57, Issue 12, 1998, Pages 862-872

  Pathak, A N ^a   Srivastava, Abha ^a  

^a U P Vigyan Bhawan ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0040186203     PISSN: 00224456     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. McGuire J M, Bunch R L & Anderson R C, Antibiot Chemother, 2 (1952) 281-3.
2. Smith R L, Bungay H R & Pittenger R C, Appl Microbiol, 10 (1962) 293-296.
3. Bosnjak M, Tporovec V & Vrana M, J Appl Chem Biotechnol, 28 (1978) 791-798.
4. Ettler J P & Greger V, J Ferm Technol, 56 (1978) 144-151.
5. Med Actual/Drugs Today (New Launches), 23 (12) (1987).
6. Chantot J F, Gare J C, Govind Ambrires & Lutz A, in 23rd Inter Guf, Antimicrob Agents Chemother (Oct 24-26, Los Angles) (1983) Abstract 447.
7. Young R A, Ganzales J P & Engere M S, Drugs, 37(1) (1989) 9-41.
8. Markham A & Faulds D, Drugs, 48 (2) (1994) 297-326.
9. Govind Ambrieres S, Lutz A, Gasc J C & Roussel-V Claf E, 33, 255 F R 2, 473, 525, JP 81, 100 79, US PAT, 4, 349, 545; Drugs of Future, Vol 11 (9), (1986) 767.
10. Finch R G, Speller D E & Daly P J, J Antimicrob Chemother, 27 (Suppl) (1991) 1-124.
11. Bryskier A & Labro M T, Presse Med, 23 (1994) 1762-1766.
12. Watanabe Y, Morimoto S & Omura S, (to Taisho Pharma Co Ltd), Eur Pat, 41, 355; Drugs of Future, 12 (10) (1987) 953.
13. Morimoto S, Adachi T, Takahashi Y, Watanabe Y, Sota & Kikugawa Y (to Taisho Pharm Co Ltd); Eur Pat, 147, 062; Drugs of Future, 12 (10) (1987) 953.
14. Gilligan P & Jack K, 26th Inter Sci Conf. Antimicrob Agents Chemother, (28-Sept to 1 Oct, New Orleans) 1986, Abst 330.
15. Reising F S, Hindler J A & Young L S, Antimicrob Agents Chemother, 31(4) (1987) 640-642.
16. Fernandes P, Bailer R, Swanson R, Hanson C W, Mc Donald E, Ramer N, Hardy D, Shipkowitz N, Bower R R & Gade E, Antimicrob Agents Chemother, 30 (6) (1986) 865-873.
17. Segreti J, Kessler H A, Kapell K S & Trenholme G M, Antimicrob Agents Chemother, 31 (1) (1987) 100-101.
18. Benson C A, Segreti J, Beaudette F E, Hines D W, Goodman L J, Kaplan R L & Trehnolme G M, Antimicrob Agents Chemother, 31 (2) (1987) 328-330.
19. Bright G M (Pfizer Inc) Eur Pat, 101, 186; Drugs of Future, 13 (1) 1988 9-13.
20. Retsema J A, Mason R J, Scheikly W U, Grirard A E & Bright G M, 26th Inter Science Conf., Antimicrob Agents Chemother, 28-Sept to 1 Oct, New Orleans (1986) Abst 934.
21. Yu K W & Neu H C, Antimicrob Agents Chemother, 34 (1990) 1839-42.
22. Rolston K V, H O D H & Leblanc Bodey G P, Eur J Clin Microbiol Infect Dis, 1 (1990) 30-3.
23. Martine Derriennic, Drugs Today, 31(2) (1995) 11-115.
24. Fernandes P B, Hardy D, J Drugs Exp Clin Res, 14 (1988) 450-1.
25. Hardy D J, Hensey D M, Beyer J M, Votj Lko C, Mc Donald E J & Fernandas P B, Antimicrob Agents Chemother, 32 (1988) 1710-9.
26. Busch U, Hemzel G, Lechner U & Koss F W, 28th Inter Sci Cong. Antimicrob Agents Chemother (Oct 23-26, Los Angeles) 1988, Abst 922.
27. Busch U & Lechner U, 28th Inter Sci conf Antimicrob Agents Chemother, (Oct 23-26, Los Angeles) 1988, Abst 925.
28. Lindstrom T D & Whitaker G W, 28th Inter Sci Conf, Antimicrob Agents Chemother, (Oct 23-26, Los Angeles) 1988, Abst 923.
29. Kirst H A, Aminoglycoside, macrolide, glycopeptide, and miscellaneous antibacterial antibiotics, Burger's Medicinal Chemistry and Drug Discovery, Vol 2. Therapeutic Agents, edited by Manfred E. Wolff (John Wiley & Sons, Inc.) 1996.